Health Inequality in the Global Burden of Chronic Obstructive Pulmonary Disease: Findings from the Global Burden of Disease Study 2019
DOI: https://doi.org/10.2147/COPD.S369120
2022-07-29
International Journal of COPD
Abstract:Haifeng Li, 1, &ast Hongsen Liang, 2, &ast Li Wei, 2 Donglei Shi, 2 Xin Su, 3 Fajun Li, 4 Junhang Zhang, 2 Zhaojun Wang 2 1 Department of Anesthesiology, Guangdong Provincial People's Hospitall, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China; 2 Department of Thoracic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, People's Republic of China; 3 Department of Respiratory, Hainan Hospital of PLA General Hospital, Sanya, People's Republic of China; 4 Department of Critical Care Medicine, The First People's Hospital of Kunshan, Suzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Junhang Zhang; Zhaojun Wang, Department of Thoracic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, 628 Zhenyuan Road, Shenzhen, People's Republic of China, Tel/Fax +86-755-81206874, Email ; Background: This study assessed health inequality in the global burden of chronic obstructive pulmonary disease (COPD) between 1990 and 2019 using data extracted from the Global Burden of Diseases (GBD 2019) study. Methods: Data were extracted from the GBD 2019 study. A series of comparative and descriptive analyses of the disease burden between women and men in countries with different socioeconomic development (SDI) status were performed. The slope index of inequality (SII), relative index of inequality (RII), and concentration index (CI) were calculated to measure the socioeconomic-related cross-national health inequity between 1990 and 2019. Results: The global health burden caused by COPD increased by 25.7% in terms of disability-adjusted life years (DALY) from 59.2 million years in 1990 to 74.4 million years in 2019. Global age-standardized DALY rate (ASDR) associated with COPD decreased by 40.0%, from 1537.7 per 100,000 population in 1990 to 926.1 per 100,000 population in 2019. The highest sex-specific DALY number was at age 70– 74 in male and female, and female is lower than male. However, after controlling for population size, the burden of COPD is more concentrated in the population living in low SDI countries, relative health inequality indicators (RII and CI) supported this conclusion. Conclusion: The health inequalities caused by the disparity of socioeconomic status are increasing, and the increasing concentration of wealth worldwide is likely to aggravate health inequalities associated with COPD. Keywords: chronic obstructive pulmonary disease, disease burden, health inequality Chronic Obstructive Pulmonary Disease (COPD), which is characterized by progressive, partially irreversible airflow limitation, is a progressive inflammatory disease. 1 It is one of the leading causes of death and disability globally, accounting for 41.9 deaths per 100,000 individuals and a total of 1068.02 DALY rate per 100,000 in 2017. 2 This may be aggravated by global population growth and the increase in the aging population in the coming decades. 3 The global health burden caused by COPD is not homogeneous, but differs according to region and gender, which can be affected by demographic characteristics, 4,5 air pollution, 6,7 and the prevalence of smoking in different countries or territories. 8 These factors reflect the health burden gap in the socioeconomic dimension between developed and non-developed countries. In the past decades, the rapid global industrialization resulted in a transfer of air pollution sources as well as the prevalence of smoking. 7–9 The continuously increasing disparities in infrastructure and accessibility to health resources between developed and non-developed countries may further increase the inequality in the COPD burden with respect to socioeconomic status. 10–12 Despite this, the literature is not up-to-date on this topic. Here, we measured the health inequality in the COPD burden by focusing on poorer countries and women. For this purpose, we performed a second analysis of the Global Burden of Diseases study (GBD 2019) to identify challenges and opportunities for reducing the disease burden and to provide evidence for policy making. The annual global, regional and national disability-adjusted life years (DALY) related to COPD, and population and socio-demographic index (SDI) data were downloaded from GBD 2019 for a second analysis. 13–15 DALY is a comprehensive measure of the quantity and quality of life in terms of time; it was first jointly proposed by Harvard University and the World Health Organization (WHO) in 1988 and successfully used in the estimation of dis -Abstract Truncated-